Announcements and Notices - [Results of AGM]

CANbridge Pharmaceuticals operates as a global biopharmaceutical company. The Company focuses on developing and commercialising therapeutics for treatment of orphan diseases and rare cancers. CANbridge Pharmaceuticals serves customers worldwide.

Poll Results Of The Annual General Meeting Held On June 27, 2024

Form Of Proxy For The Annual General Meeting To Be Held On Thursday, June 27, 2024

Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period]

Notice Of Annual General Meeting

Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Share Scheme / Re-election or Appointment of Director subject to Shareholders' Approval]

(1) Proposed General Mandates To Issue Shares
And Repurchase Shares;
 (2) Proposed Amendments To The Share Option Scheme;
 (3) Proposed Amendments To The Rsu Scheme;
 (4) Proposed Re-Election Of Directors;
 (5) Proposed Re-Appointment Of Auditor;
And
 (6) Notice Of Agm

Announcements and Notices - [Other - Business Update]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

CANbridge Pharmaceuticals (1228 HK)

Poll Results Of The Annual General Meeting Held On June 27, 2024

Form Of Proxy For The Annual General Meeting To Be Held On Thursday, June 27, 2024

Notice Of Annual General Meeting

(1) Proposed General Mandates To Issue Shares And Repurchase Shares; (2) Proposed Amendments To The Share Option Scheme; (3) Proposed Amendments To The Rsu Scheme; (4) Proposed Re-Election Of Directors; (5) Proposed Re-Appointment Of Auditor; And (6) Notice Of Agm

Change In Use Of Proceeds From The Global Offering

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)